NEUBASE THERAPEUTICS INC - COM (NBSE)

CUSIP: 64132K102

Q4 2021 13F Holders as of 31 Dec 2021

Type / Class
Equity / COM
Total 13F shares
11,232,940
Share change
+149,367
Total reported value
$31,563,000
Price per share
$2.81
Number of holders
41
Value change
-$177,231
Number of buys
14
Number of sells
18

Quarterly Holders Quick Answers

What is CUSIP 64132K102?
CUSIP 64132K102 identifies NBSE - NEUBASE THERAPEUTICS INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of NEUBASE THERAPEUTICS INC - COM (NBSE) as of Q4 2021

As of 31 Dec 2021, NEUBASE THERAPEUTICS INC - COM (NBSE) was held by 41 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 11,232,940 shares. The largest 10 holders included GREENLIGHT CAPITAL INC, VANGUARD GROUP INC, Point72 Asset Management, L.P., AIGH Capital Management LLC, CARNEGIE MELLON UNIVERSITY, Sio Capital Management, LLC, Polar Asset Management Partners Inc., JACOB ASSET MANAGEMENT OF NEW YORK LLC, PRELUDE CAPITAL MANAGEMENT, LLC, and GEODE CAPITAL MANAGEMENT, LLC. This page lists 41 institutional shareholders reporting positions in this security for the Q4 2021 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.